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Abstract: A significant body of research has considered collagen as a scaffold material for soft tissue
regeneration. The main structural component of extra-cellular matrix (ECM), collagen’s advantages
over synthetic polymers are numerous. However, for applications where higher stiffness and stability
are required, significant cross-linking may affect bioactivity. A carbodiimide (EDC) cross-linking route
consumes carboxylate groups that are key to collagen’s essential cell recognition motifs (GxOGER).
Fibrinogen was considered as a promising additive as it plays a key role in the process of wound
repair and contains RGD integrin binding sites which bind to a variety of cells, growth factors
and cytokines. Fibrinogen’s binding sites however, also contain the same carboxylate groups as
collagen. We have successfully produced highly interconnected, porous collagen-fibrinogen scaffolds
using a lyophilisation technique and micro-computed tomography demonstrated minimal influence
of either fibrinogen content or cross-linking concentration on the scaffold structure. The specific
biological effect of fibrinogen additions into cross-linked collagen are considered by using films
as a model for the struts of bulk scaffolds. By considering various additions of fibrinogen to the
collagen film with increasing degrees of cross-linking, this study demonstrates a significant biological
advantage with fibrinogen addition across the cross-linking concentrations typically applied to
collagen-based scaffolds.
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1. Introduction
A key desire in tissue engineering is to mimic and regenerate the existing native environment.
The extra-cellular matrix provides physical support to tissues by occupying the intercellular space and
acting as a native scaffolding, but is also a highly dynamic, mobile, and flexible structure which is
key to cellular behaviour and tissue function [1]. Collagen forms the major structural component of
this and, as such, there has been a significant focus of research on collagen as a scaffold material for
tissue regeneration [2–5]. However, in order to more closely replicate the ECM chemistry of specific
tissues, there has been widespread consideration of the addition of other biologically-relevant materials.
Glycosaminoglycans (GAGs), such as chondroitin-6-sulphate or hyaluronic acid, for example, have
been considered extensively for skin [6–10] and musculoskeletal engineering applications [11–13], with
hyaluronic acid additionally being considered for adipose tissue engineering [14]. GAGs form porous
hydrated gels and tend to fill most of the extra-cellular matrix space providing mechanical support
to tissues whilst also allowing for the migration of cells and diffusion of water soluble molecules [7].
GAGs may also provide mechanical advantage and improved stability [15]. Elastin, with its highly
elastic nature, is found naturally in cardiovascular tissue and has also received some attention [16,17].
Fibrinogen is a soluble 340 kDa protein found in the blood and plays a key role in blood clotting
and platelet aggregation [18]. Following vascular injury, fibrinogen is cleaved by thrombin to form
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fibrin, the most abundant protein of blood clots. Various cleavage products of fibrinogen have been
found to be released during coagulation and fibrinolysis [18], meaning it is often considered as a
haemostatic agent or for wound dressing [19–21]. Fibrinogen is a protein with the capacity to bind to
a wide array of proteins and it has been shown to regulate cell adhesion and spreading and display
vasoconstrictor and chemotactic activities [18]; its application in tissue engineered scaffolds could,
therefore, be beneficial particularly for vascular prosthetic engineering [22]. Whilst there are perhaps
some concerns with the immunological response of fibrinogen within the central nervous system,
and even links with multiple sclerosis, soluble fibrinogen within the bloodstream has not been observed
to be proinflammatory [23]. As summarised by Sell et al., fibrinogen contains RGD binding sites which
commonly bind fibroblasts and endothelial cells, and it also binds with high affinity to VEGF (vascular
endothelial growth factor), FGF (fibroblast growth factor), and a number of other cytokines [22].
A number of studies on electrospun fibrinogen scaffolds have demonstrated high levels of
bioactivity with ready migration, deposition of native collagen, and rapid remodelling [24–27], but
production of fibrinogen scaffolds through other routes is problematic [28]. Fibrin gels have received
some attention [29,30] but the lack of structural integrity limits practical use [31]. Additionally
degradation rates are rapid, with some fibrin gels dissolved within just days [32]. It, thus, appears
logical to consider fibrinogen as a secondary addition to more structurally-relevant biopolymers,
such as collagen. Whilst gelatin-fibrinogen cryogels have been considered for wound repair [33],
a fibrinogen-coated collagen patch for treatment of thoracic aortic aneurysm [34] and a number of
collagen-fibrin composites designed [35,36] the application of fibrinogen as a secondary addition in
combination with collagen warrants far greater consideration.
When collagen is generated in vivo, covalent inter- and intra-molecular bonds are formed as a
result of enzymatic and non-enzymatic cross-linking [37]. These cross-links are essential for mechanical
strength and proteolytic resistance and are not formed during the self-assembly or reconstitution of
collagen in neutral pH. The zero length cross-linker 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide
(EDC) in combination with N-hydroxysuccinimide (NHS) has been shown to be a highly effective
route for the cross-linking of collagen structures [9,10,38]. Whilst a minimal effect of bioactivity is
generally reported with the EDC cross-linking of collagen structures [38,39], higher concentrations of
the cross-linking agents have been associated with cytotoxicity [7,10]. In a recent study on extruded
collagen fibres cross-linked with the EDC-NHS chemistry, a significant increase in the attachment of
human tenocytes and a more flattened phenotypical appearance was associated with a reduction in
the cross-linking concentration [40].
In 1996 Olde-Daminck et al. investigated the optimum concentrations of reagents necessary for the
carbodiimide-based cross-linking of ovine-derived dermal collagen [41]. They determined that a ratio
of 5:2:1 EDC:NHS:carboxylic acid groups in collagen resulted in the highest degree of cross-linking and
this has become something of a standard when it comes to cross-linking concentrations for collagen
scaffolds, certainly within our research group [14,42–45]. Recent work, however, has suggested that a
lower concentration provides a better biological response with acceptable mechanics and stability [46,47].
As Davidenko et al. describe, there is a tendency for studies of cell attachment to protein-derived
matrices, such as collagen, to ignore the detailed mechanism of binding. There is very rarely any
consideration of whether binding is non-specific or integrin-mediated and, if the latter, which integrins
are responsible [47]. This can become particularly relevant when cross-linking is considered. In EDC
cross-linking, carboxylate groups on the amino acid side chains of glutamate (E) or aspartate (D)
are consumed. These groups form an integral part of the cell-recognition motifs of both collagen
and fibrinogen; collagen includes the triple-helical GxOGER sequence (where G is glycine; O is
hydroxyproline; R is arginine and x is hydrophobic, exemplified by phenylalanine, F) and fibrinogen
contains a linear RGD motif. In the recent work of Davidenko et al., carbodiimide cross-linking
was found to ablate integrin-dependent cell activity on both two-dimensional and three-dimensional
architectures of collagen and gelatin [47]. Gelatin, like fibrinogen, binds using a linear RGD cell
Materials 2017, 10, 568 3 of 17
adhesive motif and, thus, it is reasonable to assume that EDC cross-linking will affect the activity of
the fibrinogen in addition to that of the collagen.
Collagen-fibrinogen based scaffolds would appear to offer considerable biological advantage not
least in terms of the multiple available cell-recognition motifs. This work, therefore, considers the
feasibility of applying lyophilisation to the production of collagen-fibrinogen scaffolds and carries out
structural analysis investigating the effect of both fibrinogen content and cross-linking concentration
on pore structure. Whilst previous work by Ber et al. has considered the adsorption of fibrinogen to
the surface of cross-linked collagen films in a secondary process [48], in this study we aim to produce
scaffolds with an intimate mixture of collagen and fibrinogen in a single step lyophilisation process,
thus adding no additional complexity to production. Additionally, this work investigates the specific
biological effect of fibrinogen additions into cross-linked collagen films. These films can be treated as a
model for the struts of bulk scaffolds [49,50] providing information at the cellular length scale highly
relevant to cell behaviour on scaffolds and providing a simpler system where the effect of chemistry
can be more straightforwardly elucidated. Whilst common cell types typically exhibit fairly broad
reactivity to a range of integrins [51,52], this study concentrates on a C2C12 mouse myoblast cell line
with specific RGD binding receptors, thus, they should adhere specifically to fibrinogen. These cells
have, in a previous study, been shown to exhibit minimal adhesion to collagen films of any cross-linking
concentration [47]. By considering various additions of fibrinogen to the collagen film with increasing
degrees of cross-linking, this study aims to investigate whether fibrinogen can impart any biological
advantage across the cross-linking concentrations typically applied for collagen-based scaffolds.
2. Results
2.1. Production of Collagen–Fibrinogen Scaffolds and Films
Lyophilised collagen-fibrinogen scaffolds were successfully produced with between 0% and 50%
fibrinogen (0, 10, 25, and 50 wt %). and cross-linking carried out using the EDC/NHS chemistry. 100%
cross-linking concentration referred to the standard ratio of 5:2:1 EDC:NHS:carboxylic acid groups in
the collagen and fibrinogen. Reduced cross-linking concentrations of 1%, 10%, 30%, and 50% were
also analysed. Scaffolds showed comparable gross structures (Figure 1) and variation in shrinkage
associated with the freeze-drying process was not significant. Films with these compositions and 30%
cross-linking concentration were additionally produced on glass coverslips.
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In order to investigate spatial distribution of the two constituents within scaffolds and films,
a simultaneous immunofluorescence procedure was carried out and samples were imaged in the
hydrated state using confocal microscopy. The collagen associated secondary carried an Alexa Fluor 488
fluorophore, and the fibrinogen carried an Alexa Fluor 648 fluorophore (all antibodies from Abcam,
Cambridge, UK), hence, the collagen is shown in green in the images of Figures 2 and 3 and fibrinogen
in red; the separate channels along with the overlaid images are included in the figures. The chemical
distribution and the success of the immunofluorescence procedure was found to be independent of the
cross-linking concentration. In these images of 10%, 25%, and 50% fibrinogen scaffolds, a comparatively
uniform distribution of the two constituents was observed throughout the scaffold structure, with
dark areas (low signal intensity) being the result of open pores. Imaging of the composite films can
be treated as the analogue of the scaffold struts and the simpler structures perhaps provide a better
picture of the good level of mixing of the constituent reagents and, consequently, a consistent chemical
environment for cellular analysis.
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Figure 3. Investigation of fibrinogen distribution in films using immunofluorescence. Again, representative
images of the films are taken after incubation with primary antibodies for both collagen and fibrinogen
and associated secondary antibodies.
2.1.1. Structural Analysis with Micro-CT and Scanning Electron Microscopy (SEM)
Scaffolds with the full combination of compositions and cross-linking concentrations were
scanned without sectioning using a Skyscan 1172 system (Bruker Micro-CT, Kontich, Belgium). After
reconstruction, scaffold structures were observed and 1 mm3 cubic regions of interest were selected
for p rosity analysis using CTan (Bruker Micro-CT, Kontich, Belgium). Porosity analysis was carried
out in order to determi e whether ny structural variation was a sociated with changing fibrinogen
content or cross-linking concentration. I ing of section of the scaffolds were also carried out using
SEM. Figure 4 includes representative SEM images and single slices from the reconstructed micro-CT
data and demonstrates good correlation between the structures as analysed using the two techniques.
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Figure 4. Characteristic pore structures for lyophilized collagen-fibrinogen scaffolds as imaged directly
using SEM ((a) and (c)) and generated from the reconstructed micro-CT data ((b) and (d)). Micro-CT
images are at the same magnification as those from SEM. Images (a) and (b) are of a scaffold with 10%
cross-linking and 10% fibrinogen, and images (c) and (d) of a scaffold with 100% cross-linking and
50% fibrinogen.
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The mean pore size was found to vary significantly within the samples considered, with mean
values of between ca. 60 and 140 microns calculated; however, this was not associated with a systematic
dependence upon either fibrinogen content or cross-linking concentration. Perhaps of greater interest,
in terms of cell migration, is the notion of percolation diameter. The percolation diameter is the
diameter of the largest sphere able to penetrate through an infinitely large scaffold and is a scalable
measure of pore interconnectivity [42]. Mean values for the percolation diameter varied between
80 and 120 µm, but with significant associated standard deviations, no significant effect of either
fibrinogen content or cross-linking concentration were observed. It, thus, appears reasonable not to
apply too much weight to the consideration of variations in pore structure during future analysis of
the biological response of these materials.
2.2. Films for Cellular Analysis
Collagen-fibrinogen films with all fibrinogen concentrations and cross-linking at the 10% and 100%
level were successfully produced on the base of 48-well plates for analysis of cellular adhesion and
spreading. These films were designed as a model of the strut walls of the three-dimensional structures
and a first step in biological analysis. Cross-linking concentrations were selected so as to consider the
biological effects of the fibrinogen addition at low and high cross-linking concentrations and, thus, infer
something of the biological effect of fibrinogen additions across relevant cross-linking compositions.
2.2.1. Cellular Adhesion and Spreading
Cellular adhesion was investigated using a C2C12 mouse myoblast cell line with specific RGD
binding receptors and in the presence of either Mg2+ or EDTA in order to isolate integrin (Mg2+) versus
non-integrin (EDTA) adhesion. The effect of fibrinogen content was considered at 10% (Figure 5a) and
100% cross-linking concentrations (Figure 5b).
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Figure 5. Percent adherence of seeded cells as a function of the percent of fibrinogen in film (a) at 10%
cross-linking concentration; and (b) 100% cross-linking concentration; and (c) a comparison of the
percent adhesion to bovine serum albumin (BSA) and tissue cultured plastic (TCP) controls at 100%
cross-linking concentration. Adhesion is shown in the presence of 5 µM Mg2+ or EDTA.
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In the case of the 10% cross-linking concentration in the presence of Mg2+, cells were observed
to be highly adherent even in the absence of fibrinogen. Non-specific adhesion (in the presence of
EDTA) was low in the case of low cross-linking concentration. In the case of the 100% cross-linking
concentration, the percentage of adherent cells increased linearly between 0% and 25% fibrinogen,
before plateauing with around 90% adherent cells at 50% fibrinogen. This specific adhesion at
elevated fibrinogen levels was higher even than the positive control TCP (tissue cultured plastic)
(Figure 5c). Non-specific adhesion (in the presence of EDTA) was significantly increased with the
higher cross-linking concentration and decreased with increasing fibrinogen content.
As a consequence of the very clear effect of fibrinogen concentration on cell adhesion at
the maximum cross-linking level, cell spreading was investigated using only this cross-linking
concentration. In a quantitative analysis 0% and 50% fibrinogen-containing films were compared to
negative control bovine serum albumin (BSA) and positive control tissue cultured plastic (TCP). All cell
spreading was investigated in the presence of Mg2+ to consider only specific binding. With phase
contrast, cells on the 0% fibrinogen surface were observed to be highly rounded (Figure 6a) with an
approximately 10-fold increase in cell spreading observed on the films containing 50% fibrinogen
(Figure 6b,e) compared to the collagen-only material.
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The nature of the cell spreading was further investigated across the fibrinogen additions by way
of CellTracker Green CMFDA prestaining of the cells (Figure 7). The number of rounded cells was
observed to decrease significantly with increasing fibrinogen concentration with highly-spread cells
observed at the 25% and 50% fibrinogen levels.
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week period where free dyes were dialysed off in 0.05 M acetic acid solution. Samples were imaged 
using confocal microscopy and a highly uniform distribution of the two components observed. 
Immunofluorescence is a standard technique widely applied across microbiology, cell biology, and 
tissue engineering whereby highly specific antibodies adhere only to the molecules of interest and 
fluorescent markers excite at specific wavelengths for confocal or fluorescent imaging. As both 
collagen and fibrinogen are extremely common biomolecules, those specific antibodies are well 
developed and the novel application to engineered scaffolds provided a comparatively simple and 
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the novel application to engineered scaffolds provided a comparatively simple and highly-accurate
method of the determination of chemical special distribution.
Analysis of the biological response of a scaffold material is a complex mix of chemistry, pore
structure, as well as strut surface topography [54,55]. Literature has demonstrated that scaffold
structure has a significant effect on cellular response hence the analysis of pore structure variation
carried out here. Murphy et al. investigated the effect of mean pore size in collagen-GAG lyophilised
scaffolds on osteoblast adhesion and early stage migration. While an early peak in cell adhesion
was observed at the smaller pore sizes (120 microns), perhaps as a result of higher specific surface
area, larger pore sizes (300 micron+) were generally associated with improved cell migration [56].
The structure is important in terms of both nutrient transfer and development of a vascular network
and for cellular migration. In a study by Karageorgiou and Kaplan pore size was shown to affect the
progression of osteogenesis. Small pores favoured hypoxic conditions and induced osteochondral
formation before osteogenesis, while large pores, that were well-vascularized, led to direct osteogenesis
(without preceding cartilage formation) [57]. Micro-computed tomography was, thus, carried out in our
current study in order to investigate whether either fibrinogen content or cross-linking concentration
had any systematic and significant effect on the pore structure. Although variation in the mean pore
sizes were significant, there was no correlation with either of the two considered variables.
Whilst pore size is an important variable for consideration, of greater interest perhaps, is the
idea of scaffold interconnectivity. It has recently been demonstrated by Ashworth et al. that pore
size and interconnectivity can be independently controlled within a freeze-dried scaffold. In a cell
invasion study with primary human fibroblasts in samples with comparable pore sizes, smaller
percolation diameter (reduced interconnectivity) were associated with markedly reduced cell invasion.
As Ashworth et al. state, optimization of pore size should be considered ‘an incomplete approach
to the enhancement and control of cell invasion, and that an understanding of interconnectivity is
required to ensure efficient cell movement into a structure’ [42]. Percolation diameters calculated
across the range of fibrinogen contents and cross-linking concentration were broadly similar, thus, it is
reasonable that even with variations in mean pore size of all of the collagen-fibrinogen scaffolds could
be treated as comparable structures from a cellular perspective.
A mass of published data concerns the optimization of cross-linking chemistries for collagen-based
scaffolds [10,37,45,52]. The EDC-NHS cross-linking method, whilst generally demonstrating favourable
behaviour compared to other physical and chemical cross-linking methods [9,10,37], has more recently
been found to ablate integrin-dependent cell activity on both 2D and 3D architectures [47,50]. The cell
adhesion analysis carried out here is based upon the recent study of Davidenko et al., where the cell
binding to two- and three-dimensional architectures consisting of collagen and gelatin were evaluated
using cell types with specific collagen and gelatin binding integrins. Like fibrinogen, gelatin exhibits
RGD integrin binding sites and cell adhesion was considered using the C2C12 cell line. Cell-lines with
targeted collagen binding integrins were additionally considered and in both cases the effect was the
same: carbodiimide cross-linking was found to ablate integrin-dependent cell activity on both 2D and
3D architectures. C2C12 cells should not have exhibited binding to collagens GxOGER sequence yet in
the case of the low cross-linking concentration (Figure 6a) specific binding was high and independent
of fibrinogen content. A previous four hour adhesion study showed no adhesion of C2C12 cells to
a collagen film [58], but more recent unpublished work has supported adhesion in the cases such as
these where films are produced from more fibrillar insoluble collagen.
Given the targeted nature of the C2C12 cells, an increase in cell adhesion and spreading with
the increase in fibrinogen content was to be expected. However the cell analysis was designed to
elucidate whether the biological activity of the fibrinogen could successfully be maintained within
a cross-linked collagen-fibrinogen scaffold. As previously mentioned, cellular analysis was carried
out on films as analogues for the scaffold strut walls so as to deconvolute considerations of chemical
and dimensional variation [47]. Future analysis will clearly have to take into consideration the
additional complexity associated with the biological response to three-dimensional environments but
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the results summarised in Figures 5–7 demonstrate maintenance of fibrinogen’s biological activity.
With the addition of 25% or 50% fibrinogen, cells were observed to be highly adherent and well-spread
even when employing cross-linking concentrations where specific binding has been shown to be
ablated in collagen. Fibrinogen thus appears to offer biological advantage at high cross-linking
concentrations perhaps considered for high stiffness or stability. The alternative binding sites of the
fibrinogen, however, also offer a greater degree of flexibility in terms of varied cell adhesion and
protein attachment across a wide range of cross-linking concentrations, thus, increasing the possible
application of lyophilized collagen scaffolds.
4. Materials and Methods
4.1. Study Design
Collagen-fibrinogen scaffolds and films were produced as summarised in Table 1.
Table 1. Summary of the samples produced for analysis where: µCT—micro-computed tomography,
sIF—scaffold immunofluorescence, fIF—film immunofluorescence, CA—cellular adhesion, and CS—cell
spreading. All samples were produced in triplicate (although detailed analysis was carried out only
on single representative samples in the case of micro-CT and immunofluorescence) except films for




1% 10% 30% 50% 100%
0% µCT, sIF µCT, sIF, CA µCT, sIF, fIF µCT, sIF µCT, sIF, CA, CS
10% µCT, sIF µCT, sIF, CA µCT, sIF, fIF µCT, sIF µCT, sIF, CA, CS
25% µCT, sIF µCT, sIF, CA µCT, sIF, fIF µCT, sIF µCT, sIF, CA, CS
50% µCT, sIF µCT, sIF, CA µCT, sIF, fIF µCT, sIF µCT, sIF, CA, CS
4.2. Collagen–Fibrinogen Scaffolds
Lyophilised structures were produced with 0%, 10%, 25%, and 50% fibrinogen. Type I insoluble
collagen from Bovine Dermis (Devro Medical, Moodiesburn, Scotland) was swollen for 48 h in 0.05 M
acetic acid at 4 ◦C prior to blending (Waring commercial blender) and vacuum degassing in order
to produce a 1 wt % suspension. Lyophilised fibrinogen (from human blood plasma, plasminogen
depleted (Enzyme Research, Swansea, UK)) was dissolved in phosphate-buffered saline solution (PBS)
at 37 ◦C to form a 1 wt % solution. The two components could be combined only through gentle mixing
as anything more vigorous resulted in foaming of the fibrinogen solution. Samples were produced in
standard 24-well plates (Corning, NY, USA) with 2 mL of slurry pipetted per sample.
Freeze-drying was carried out using a VirTis AdVantage Freeze dryer (SP Scientific, Warminster,
PA, USA) with a cooling rate of 0.17 ◦C/min to a primary freezing temperature of −20 ◦C, and drying
at 0 ◦C for 1200 min at a pressure of 80 mTorr. After cross-linking then rigorous washing, samples
were freeze-dried, again applying the same thermal profile.
4.3. Cross-Linking
Cross-linking was carried out using an EDC/NHS (1-ethyl-3-(3–dimethylaminopropyl)
carbo-diimide/N-hydroxysuccinimide) chemistry (both reagents from Fisher Scientific). 100%
concentration referred to a ratio of 5:2:1 EDC:NHS:COOH groups in collagen/fibrinogen [59] with
concentrations of 1%, 10%, 30%, and 50% also considered. It was felt to be important that with up
to 50% fibrinogen being added to the structure, the chemistry of the fibrinogen should be taken into
account when it came to the calculation of cross-linking concentrations. The fibrinogen structure is
more complicated than collagen with the human fibrinogen molecule being composed of three pairs of
non-identical chains (α2β2γ2). As carboxyl groups exist at the C-terminus of each polypeptide chain,
and within groups of aspartic acid (Asp,D) and glutamic acid (Glu,E), using the protein sequences of
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the three chains [60,61] it was calculated that the number of carboxyl groups per fibrinogen molecule
totalled approximately 500. Analysis determined that whilst this 5:2:1 ratio for collagen equated to
1.14 g EDC and 0.276 g NHS per 1 g collagen, for every gram of fibrinogen the quantities were 1.31 g
EDC and 0.333 g NHS.
Cross-linking reagents were dissolved in 95% ethanol and samples were soaked for 2 h within the
well plate before thorough washing (5 × 5 min with deionised water).
4.4. Analysis of Distribution of Collagen and Fibrinogen
A simultaneous incubation procedure was carried out with monoclonal antibodies for collagen
and fibrinogen (all antibodies provided by AbCam, Cambridge, UK). All samples were initially
incubated in 1% bovine serum albumin (BSA) in PBST (phosphate-buffered saline solution with 0.1%
Tween 20) before a one hour incubation with primary antibodies at room temperature (anti-collagen I
rabbit and anti-fibrinogen goat). After 3 × 5 min static washes with PBS, samples were then incubated
with secondary antibodies (Donkey Anti-rabbit Alexa Fluor 488 and Donkey Anti-goat Alexa Fluor 647),
washed repeatedly, and samples were mounted for confocal imaging (Leica SP2). It was not possible
to produce scaffolds or, indeed, films consisting of 100% fibrinogen, so specificity of the antibodies
were not fully verified, however, analysis of 100% collagen films in the presence of all primary and
secondary antibodies did not demonstrate any fibrinogen-associated signal (Figure 8). Distribution of
collagen and fibrinogen within both films and scaffolds was then determined.
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the largest sphere able to penetrate through an infinitely large scaffold. For percolation analysis three
ROIs of dimension 1 mm × 1 mm × 1 mm were modified to allow penetration only from the top and
bottom x-y planes. The analysis was carried out using a method described by Ashworth et al. [42].
Briefly, CTAn’s shrink wrap feature was used to identify the volume accessible to a virtual object.
By increasing the diameter of this object ‘d’, the corresponding length of accessible pore volume ‘l’ in
the z direction could be measured and this data plotted using the relationship from percolation theory
in order to calculate the percolation diameter:
L = Lo(d − dc)−v (1)
where v is 0.88 for a 3D system [64].
Additionally, through-thickness sections of the scaffolds were produced using a scalpel, gold
coated and imaged, using scanning electron microscopy (JEOL 5800, JEOL, Welwyn Garden City, UK).
4.6. Collagen-Fibrinogen Films
Collagen-fibrinogen films were produced with the same compositions as considered for
the lyophilized structures (0%, 10%, 25%, and 50% fibrinogen with a total 1 wt % solids).
For immunofluorescence these films were produced on circular glass coverslips with 106 µL suspension
per sample. Films were additionally cast on the base of standard 48 well plates for cell culture with
76 µL of the suspension pipetted per well. All samples were air-dried. Cross-linking was carried out
at the 30% cross-linking level for immunofluorescence samples and the 10% and 100% level for cell
samples, before rigorous washing (5 × 5 min wash with D.I. H2O). Cross-linking in ethanol solution
was sufficient sterilisation for short-term cell culture and film samples were handled aseptically after
this point.
4.7. Cell Culture
A preliminary study of cell attachment and spreading was carried out using the C2C12 mouse
myoblast cell line. Films produced on the base of 48 well plates with all fibrinogen additions and 100%
and 10% cross-linking concentrations were considered with four replicates per sample type. In order
for the specific integrin binding of cells, divalent cations, such as magnesium are necessary [51,65],
thus, our cell adhesion was carried out in the presence of Mg2+. In line with previous studies [47]
integrin-based and non-integrin-based cell binding were separated through adhesion assays run in
the presence of EDTA, used to remove divalent ions by chelation. The C2C12 mouse myoblast cell
line was maintained in a humidified incubator with 5% CO2 at 37 ◦C in Dulbecco’s modified Eagle’s
medium (DMEM, Sigma-Aldrich) containing 10% (v/v) foetal bovine serum (Sigma-Aldrich) and 1%
(v/v) streptomycin/penicillin (Sigma-Aldrich). Cells were prepared for cell analysis by detaching from
the cell culture flasks with 0.05% (w/v) trypsin/0.02% (w/v) EDTA (Sigma-Aldrich) and re-suspending
in serum free DMEM to a density of 2 × 105 cells/mL.
4.7.1. Cell Adhesion Analysis
Non-specific adsorption was blocked with 250 µL of 5% (w/v) bovine serum albumin (BSA)
(Sigma Aldrich, Gillingham, UK) in phosphate-buffered saline (PBS) (Sigma Aldrich, Gillingham,
UK) for 60 min, and then washed three times with 250 µL of PBS. Two-hundred microlitres of cells
were added to each well in serum-free DMEM (Sigma Aldrich, Gillingham, UK) containing either
5 mM MgCl2 or 5 mM ethylenediaminetetraacetic acid (EDTA) (Sigma Aldrich, Gillingham, UK). After
incubation at 37 ◦C/5% CO2 for 45 min, loosely-bound cells were removed with 3 × 250 µL PBS
washes. Bound cells were lysed with 100 µL of 2% (v/v) Triton X-100 for 4 h at room temperature then
detected by adding 100 µL of lactate dehydrogenase (LDH) substrate (Sigma-Aldrich, Gillingham,
UK) prepared according to the manufacturer’s specifications. After 30 min of incubation at room
temperature the absorbance at 490 nm was measured using a BMG LABTECH SPECTROstar Nano
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plate reader (BMG LABTECH Ltd, Aylesbury, UK). Values are presented as means of quadruplicate
measurements ± standard deviations.
4.7.2. Cell Spreading Analysis
Films were BSA-blocked as for attachment analysis. Near confluent cell monolayers were washed
with serum free DMEM then incubated in serum free DMEM containing 5 µM CellTracker Green
CMFDA (5-chloromethylfluorescein diacetate)(Molecular Probes, Eugene, OR, USA) for 30 min at
37 ◦C/5% CO2. The cells were washed with serum free DMEM then detached from the flask with
0.05% (w/v) trypsin/0.02% (w/v) EDTA (Sigma-Aldrich, Gillingham, UK) and re-suspending in serum
free DMEM to a density of 2 × 105 cells/ml. Two-hundred microlitres of cells were added to each
well in serum-free DMEM for 120 min at 37 ◦C/5% CO2. Subsequently the cells were fixed by the
addition of glutaraldehyde (Sigma-Aldrich, Gillingham, UK) to the cell medium to achieve a final
concentration of 5% (w/v) for 20 min at room temperature. The wells were extensively washed with
PBS, the wells filled with PBS, then a glass slide layered across the well plate. Cell images were taken
on a Zeiss Axio Observer Z1 phase contrast microscope fitted with a Zeiss Axiocam 503 mono camera
using a 10× objective lens (Carl Zeiss Ltd, Cambridge, UK). Cell spreading was quantified by scoring
a cell as 'spread if it was phase-dark with cellular projections and had a flattened morphology. Cells
were scored as non-spread if rounded and phase-bright with no cellular projections, as detailed in [66].
The percentage cell spreading was calculated by dividing the number of spread cells by the total
number of cells present. Values are means of quadruplicate measurements ± standard deviation
4.8. Statistical Analysis
The normality of cell spreading data was tested using the Shapiro-Wilks test of normality.
Statistical significance was determined through a one-way ANOVA, followed by Tukey’s HSD.
Significance was defined as p < 0.05.
5. Conclusions
Novel lyophilized collagen-fibrinogen scaffolds have been produced across a range of fibrinogen
contents and cross-linking concentrations. Applying, for the first time, immunofluorescence to the
characterization of produced scaffolds, distributions of the two constituents were shown to be uniform
at up to 50% fibrinogen and despite some variations in mean pore size, the interconnected nature of
the scaffolds was broadly independent of composition and cross-linking. Using films as a model of
the strut surfaces of scaffolds, the work has demonstrated a significant biological advantage to the
addition of fibrinogen within collagen structures, particularly at levels of cross-linking where specific
binding to collagen has previously been shown to be ablated.
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